What are the ACVC Biomarker Talks?
This series was designed by course directors
ACVC Biomarker Talks
A project from the ACVC Biomarkers Study Group
Professor Christian Eugen Mueller
Past Chair
Professor Nicholas Mills
Chair
Associate Professor Johannes Mair
Chair-elect
The talks, in a nutshell:
- Online events covering each topic in the biomarker field
- Each talk will be moderated by ACVC Biomarker Study group members and discussed with experts.
2026 - New! Season 3
- January 2026: Cardiac biomarkers in prehospital and primary care settings, presented by Louise Cullen with Tonje Johannessen and Rick Body
- February 2026: Exercise-induced cardiac troponin release: do we need to worry?
- March 2026: Proteomics profiling for cardiovascular risk prediction
- April 2026: Risk stratification in acute myocardial infarction.
ACVC Biomarker Talks Season 3
EHJ - Acute Cardiovascular Care
Exercise-induced cardiac troponin release: do we need to worry?
21 Jan 2026 - 00:00
EHJ - Acute Cardiovascular Care
New pathways with high-sensitivity cardiac troponin testing at the point of care in the ambulance and primary care
2 Dec 2025 - 00:00
Webinar
ACVC Biomarker Talk - Cardiac biomarkers in prehospital and primary care settings
20 Jan 2026 - 01:00
Webinar
ACVC Biomarker Talk - Exercise-induced cardiac troponin release: do we need to worry?
15 Feb 2026 - 01:00
Watch Season 2 (2023/2024)
- Avril 2023: High sensitivity cardiac troponin in stable ASCVD, presented by David Morrow
- May 2023: How to use cardiac troponin T or cardiac troponin I in noncardiac surgery, presented by Christian Puelacher
- June 2023: Troponin T and I: back to basics, presented by Alma Mingels
- September 2023: Cardiac biomarkers in pulmonary embolism, presented by Evangelos Giannitsis
- November 2023: Cardiac biomarkers post PCI, presented by Allan Jaffe
- May 2024: How to use BNP/NT-proBNP in patients undergoing non-cardiac surgery, presented by Emmanuelle Duceppe
- June 2024: Natriuretic peptides and algorithms to support the diagnosis of acute heart failure, presented by Ken Lee
- December 2024: Clinical decision support with cardiac biomarkers in acute chest pain, presented by Martin Than
Watch season 1 (2022)
About the ACVC Study Group on Biomarkers
Background
The ACVC Study Group on Biomarkers was established by Kristian Thygesen (DK) in 2005 with the intention of creating a support group for the Global Task Force for the Definition of Myocardial Infarction (later called Universal Definition of Myocardial Infarction - UDMI).
In addition to supporting the UDMI, this group became successful and independent and now focuses on the proper clinical application of cardiac biomarkers including troponins, natriuretic peptides, and inflammatory and thrombotic markers in acute cardiac care.
Objectives
- disseminating knowledge about the proper clinical application of cardiac biomarkers in acute cardiovascular care;
- advising on the appropriate application of biomarkers in cardiovascular research;
- creating recommendations/guidelines for implementation of cardiac biomarkers in acute cardiac care; and
- being a counselling source for authorities regarding the appropriate clinical use of cardiac biomarkers.